1995
DOI: 10.1111/j.1440-1819.1995.tb01909.x
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacokinetics of slow‐release preparations of sodium valproate

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2004
2004
2004
2004

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…To compensate for the short half‐life of VPA, its slow‐release form (VPA‐R) has been widely used, with prolonged T max by the gradual dissolution keeping the same AUC. As some granule type VPA‐R may dissolve faster in a high humidity, they should be carefully storaged so as to maintain their sustained release properties 7 . Twice‐a‐day administration of VPA‐R minimizes serum level variations with lowered C max and elevated C min , but once‐a‐day VPA‐R enlarges serum variation with lowered C max and C min , compared with twice‐a‐day VPA.…”
Section: Factors Influencing Serum Drug Concentrationsmentioning
confidence: 99%
“…To compensate for the short half‐life of VPA, its slow‐release form (VPA‐R) has been widely used, with prolonged T max by the gradual dissolution keeping the same AUC. As some granule type VPA‐R may dissolve faster in a high humidity, they should be carefully storaged so as to maintain their sustained release properties 7 . Twice‐a‐day administration of VPA‐R minimizes serum level variations with lowered C max and elevated C min , but once‐a‐day VPA‐R enlarges serum variation with lowered C max and C min , compared with twice‐a‐day VPA.…”
Section: Factors Influencing Serum Drug Concentrationsmentioning
confidence: 99%